UBS Group’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $70 | Buy |
|
|||||
|
2024
Q2 | $109 | Buy |
|
|||||
|
2024
Q1 | $7 | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $18 | Sell |
|
|||||
|
2023
Q2 | $318 | Sell |
|
|||||
|
2023
Q1 | $124 | Sell |
|
|||||
|
2022
Q4 | $150 | Buy |
|
|||||
|
2022
Q3 | $0 | Hold |
|
|||||
|
2022
Q2 | $0 | Buy |
|
|||||
|
2022
Q1 | $0 | Buy |
|
|||||
|
2021
Q4 | $1K | Buy |
|